These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1746899)

  • 21. Clinicopathological study of cellular proliferation and invasion in gliomatosis cerebri: important role of neural cell adhesion molecule L1 in tumour invasion.
    Suzuki T; Izumoto S; Fujimoto Y; Maruno M; Ito Y; Yoshimine T
    J Clin Pathol; 2005 Feb; 58(2):166-71. PubMed ID: 15677537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image analysis of nuclear DNA content and morphometric characteristics of the tumor cells in human astrocytomas.
    Saito A; Yoshii Y; Nose T
    Noshuyo Byori; 1994; 11(2):143-6. PubMed ID: 7894615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological study on malignant glioma--with special reference to GFAP].
    Tajika T; Kubo O; Tajika Y; Toyama T; Himuro H; Inoue N; Sakairi M; Kitamura K
    No Shinkei Geka; 1986 Jun; 14(7):831-5. PubMed ID: 3020463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
    Li J; Pearl DK; Pfeiffer SE; Yates AJ
    J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of monoclonal antibodies to glial fibrillary acidic protein in the cytologic diagnosis of brain tumors.
    Chen Y; Zhang YX
    Acta Cytol; 1989; 33(6):922-8. PubMed ID: 2588925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
    Yamada SM; Bruner JM; Berger MS; Morrison RS
    No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine.
    Hoshino T; Nagashima T; Murovic J; Levin EM; Levin VA; Rupp SM
    Cytometry; 1985 Nov; 6(6):627-32. PubMed ID: 2998714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity of glial cell components in pilocytic astrocytoma.
    Tanaka Y; Sasaki A; Ishiuchi S; Nakazato Y
    Neuropathology; 2008 Aug; 28(4):399-407. PubMed ID: 18312545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Keratin expression in astrocytomas: an immunofluorescent and biochemical reassessment.
    Kriho VK; Yang HY; Moskal JR; Skalli O
    Virchows Arch; 1997 Aug; 431(2):139-47. PubMed ID: 9293896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody to intermediate filament proteins in astrocytes.
    Pixley SK; Kobayashi Y; de Vellis J
    J Neurosci Res; 1984; 12(4):525-41. PubMed ID: 6210375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity.
    Rutka JT; Smith SL
    Cancer Res; 1993 Aug; 53(15):3624-31. PubMed ID: 8339269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histological grading, DNA content, cell proliferation and survival of patients with astroglial tumors.
    Zaprianov Z; Christov K
    Cytometry; 1988 Jul; 9(4):380-6. PubMed ID: 2841078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MAGE-1, a cancer/testis-antigen, expression in childhood astrocytomas as an indicator of tumor progression.
    Bodey B; Siegel SE; Kaiser HE
    In Vivo; 2002; 16(6):583-8. PubMed ID: 12494904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of non-glial intermediate filament proteins in gliomas.
    Hirato J; Nakazato Y; Ogawa A
    Clin Neuropathol; 1994; 13(1):1-11. PubMed ID: 7518371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.